Composite Claim: Protein Aggregation Becomes Toxic Through Failed Clearance Interfaces

title: "Composite Claim: Protein Aggregation Becomes Toxic Through Failed Clearance Interfaces"
entity_type: convergence_synthesis
task_id: b010bbfa-414f-4bda-a1e6-ad769510df07
generated_at: 2026-04-28 06:57:40Z

Composite Claim: Protein Aggregation Becomes Toxic Through Failed Clearance Interfaces

Composite claim. Protein aggregation hypotheses converge on the idea that aggregates are most pathogenic when they jam clearance interfaces: chaperone-mediated autophagy, mitochondrial quality control, lipid trafficking, RNA granules, and protease access points.

Points of divergence. The hypotheses differ on whether the toxic species is APOE4 conformation, SNCA oligomer binding to LAMP2A, TDP-43 or RNA granule assembly, BACE1 trafficking, or mitochondrial quality-control collapse. They also differ on whether therapy should stabilize proteins, enhance degradation, or redirect trafficking.

Combined evidence strength. Combined evidence strength is moderate-high. The cluster has fewer hypotheses than neuroinflammation but the top entries are mechanistically specific and repeatedly connect aggregation to cell biology rather than treating aggregates as generic deposits.

Synthesis

title: "Composite Claim: Protein Aggregation Becomes Toxic Through Failed Clearance Interfaces"
entity_type: convergence_synthesis
task_id: b010bbfa-414f-4bda-a1e6-ad769510df07
generated_at: 2026-04-28 06:57:40Z

Composite Claim: Protein Aggregation Becomes Toxic Through Failed Clearance Interfaces

Composite claim. Protein aggregation hypotheses converge on the idea that aggregates are most pathogenic when they jam clearance interfaces: chaperone-mediated autophagy, mitochondrial quality control, lipid trafficking, RNA granules, and protease access points.

Points of divergence. The hypotheses differ on whether the toxic species is APOE4 conformation, SNCA oligomer binding to LAMP2A, TDP-43 or RNA granule assembly, BACE1 trafficking, or mitochondrial quality-control collapse. They also differ on whether therapy should stabilize proteins, enhance degradation, or redirect trafficking.

Combined evidence strength. Combined evidence strength is moderate-high. The cluster has fewer hypotheses than neuroinflammation but the top entries are mechanistically specific and repeatedly connect aggregation to cell biology rather than treating aggregates as generic deposits.

Synthesis

The shared claim across the protein aggregation cluster is that aggregate toxicity depends less on the mere presence of misfolded proteins and more on where those species interfere with cellular logistics. The top hypotheses do not describe aggregation as a passive plaque-or-inclusion endpoint. They describe aggregation-prone conformers as active blockers of clearance machinery, mitochondrial quality control, vesicle trafficking, RNA condensate dynamics, and lipid transport. This creates a useful composite mechanism: disease proteins become dangerous when they occupy bottlenecks that normally renew membranes, remove damaged organelles, traffic enzymes, or keep RNA and protein assemblies reversible.

Several source hypotheses support this convergence. APOE4 stabilization and chaperone-style rescue models emphasize that changing conformation can alter downstream lipid handling and amyloid-processing risk. SNCA-LAMP2A hypotheses point to a physical obstruction of chaperone-mediated autophagy at the lysosomal membrane. Mitochondrial deacetylation and PINK1-Parkin hypotheses connect proteostatic strain to failed mitophagy. TDP-43 and RNA granule variants extend the same logic to phase-separated assemblies: a normally reversible condensate becomes pathological when stress, post-translational modification, or binding imbalance makes it too stable to clear.

The unresolved tensions are mostly about hierarchy and intervention. One branch treats protein conformation as the primary lever: stabilize APOE4, alter tau or SNCA post-translational states, or prevent seed-competent structures. Another branch treats clearance machinery as primary: increase CMA, lysosomal biogenesis, mitophagy, or chaperone capacity so toxic assemblies cannot persist. A third branch argues that localization and trafficking are the key failure points, meaning the same aggregate load may have different effects depending on whether it is at a synapse, lysosome, mitochondrial contact site, or RNA granule.

The combined evidence strength is credible but not settled. The cluster has recurring mechanistic specificity and strong biological plausibility, yet many claims still require discriminating experiments that measure aggregate species, compartment occupancy, and clearance flux in the same system. The composite synthesis should therefore guide tests that ask whether correcting a clearance interface reduces toxicity even when aggregate burden is only partially changed.

Source Hypotheses

Cluster query matched 18 hypotheses. The synthesis above was written from the top five by `composite_score`:

Provenance

Generated by the Senate convergence monitor for task `b010bbfa-414f-4bda-a1e6-ad769510df07`. The corresponding artifact is `wiki-convergence-synthesis-protein-aggregation-clearance` and source hypotheses are linked in both directions through `artifact_links`.